Mary Litzinger

1.6k total citations
15 papers, 1.3k citations indexed

About

Mary Litzinger is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Mary Litzinger has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Mary Litzinger's work include Cancer Cells and Metastasis (9 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mary Litzinger is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mary Litzinger collaborates with scholars based in United States, Italy and Ukraine. Mary Litzinger's co-authors include Claudia Palena, Romaine I. Fernando, Duane H. Hamilton, Jeffrey Schlom, Marianne D. Castillo, Paola Trono, Douglas W. Grosenbach, Tyler J. Curiel, Kwong Y. Tsang and James W. Hodge and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Mary Litzinger

15 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Litzinger United States 13 721 582 454 288 189 15 1.3k
Sajida Piperdi United States 17 521 0.7× 252 0.4× 410 0.9× 464 1.6× 222 1.2× 25 1.1k
Nadem Soufir France 22 649 0.9× 178 0.3× 877 1.9× 231 0.8× 323 1.7× 47 1.7k
Nicholas C. DeVito United States 13 457 0.6× 487 0.8× 374 0.8× 123 0.4× 173 0.9× 31 935
A. K. El-Naggar United States 15 703 1.0× 279 0.5× 692 1.5× 163 0.6× 221 1.2× 24 1.5k
Igor Matushansky United States 21 593 0.8× 134 0.2× 1.1k 2.5× 576 2.0× 313 1.7× 48 1.8k
Adina Figl Germany 7 535 0.7× 187 0.3× 909 2.0× 185 0.6× 285 1.5× 8 1.6k
Philippe Pujuguet Belgium 16 446 0.6× 112 0.2× 542 1.2× 140 0.5× 153 0.8× 22 1.1k
Meghna Waghray United States 15 623 0.9× 192 0.3× 663 1.5× 299 1.0× 261 1.4× 15 1.4k
Dan Branstetter United States 7 588 0.8× 354 0.6× 486 1.1× 81 0.3× 210 1.1× 9 1.1k
Koroku Kato Japan 22 433 0.6× 125 0.2× 466 1.0× 100 0.3× 250 1.3× 51 1.1k

Countries citing papers authored by Mary Litzinger

Since Specialization
Citations

This map shows the geographic impact of Mary Litzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Litzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Litzinger more than expected).

Fields of papers citing papers by Mary Litzinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Litzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Litzinger. The network helps show where Mary Litzinger may publish in the future.

Co-authorship network of co-authors of Mary Litzinger

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Litzinger. A scholar is included among the top collaborators of Mary Litzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Litzinger. Mary Litzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Palena, Claudia, Mario Roselli, Mary Litzinger, et al.. (2014). Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis. JNCI Journal of the National Cancer Institute. 106(5). 62 indexed citations
2.
Huang, Bonnie, Joseph R. Cohen, Romaine I. Fernando, et al.. (2013). The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies. Cell Death and Disease. 4(6). e682–e682. 68 indexed citations
3.
Cohen, Joseph R., Romaine I. Fernando, Duane H. Hamilton, et al.. (2013). Abstract 1489: The T-box transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to chemotherapy and radiation.. Cancer Research. 73(8_Supplement). 1489–1489. 1 indexed citations
4.
Hamilton, Duane H., Mary Litzinger, Alessandra Jales, et al.. (2013). Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine. Oncotarget. 4(10). 1777–1790. 54 indexed citations
5.
Roselli, Mario, Romaine I. Fernando, Fiorella Guadagni, et al.. (2012). Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer. Clinical Cancer Research. 18(14). 3868–3879. 102 indexed citations
6.
7.
Fernando, Romaine I., Marianne D. Castillo, Mary Litzinger, Duane H. Hamilton, & Claudia Palena. (2011). IL-8 Signaling Plays a Critical Role in the Epithelial–Mesenchymal Transition of Human Carcinoma Cells. Cancer Research. 71(15). 5296–5306. 319 indexed citations
8.
Palena, Claudia, et al.. (2011). Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells. Experimental Biology and Medicine. 236(5). 537–545. 26 indexed citations
9.
Litzinger, Mary, Kenneth A. Foon, Kwong-Yok Tsang, Jeffrey Schlom, & Claudia Palena. (2010). Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells. Leukemia Research. 34(10). 1351–1357. 7 indexed citations
10.
Fernando, Romaine I., Mary Litzinger, Paola Trono, et al.. (2010). The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. Journal of Clinical Investigation. 120(2). 533–544. 206 indexed citations
11.
Litzinger, Mary, Kenneth A. Foon, Helen Sabzevari, et al.. (2008). Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients. Cancer Immunology Immunotherapy. 58(6). 955–965. 12 indexed citations
12.
Litzinger, Mary, Romaine I. Fernando, Tyler J. Curiel, et al.. (2007). IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood. 110(9). 3192–3201. 151 indexed citations
13.
Palena, Claudia, Dmitrii E. Polev, Kwong Y. Tsang, et al.. (2007). The Human T-Box Mesodermal Transcription Factor Brachyury Is a Candidate Target for T-Cell–Mediated Cancer Immunotherapy. Clinical Cancer Research. 13(8). 2471–2478. 127 indexed citations
14.
Arlen, Philip M., Lisa Skarupa, Mary Pazdur, et al.. (2007). Clinical Safety of a Viral Vector Based Prostate Cancer Vaccine Strategy. The Journal of Urology. 178(4). 1515–1520. 95 indexed citations
15.
Litzinger, Mary, et al.. (2005). Mechanisms of Gene Therapy for Tolerance: B7 Signaling Is Required for Peptide-IgG Gene-Transferred Tolerance Induction. The Journal of Immunology. 175(2). 780–787. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sajida Piperdi Breakdown of academic impact, for papers by Nadem Soufir Breakdown of academic impact, for papers by Nicholas C. DeVito Breakdown of academic impact, for papers by A. K. El-Naggar Breakdown of academic impact, for papers by Igor Matushansky Breakdown of academic impact, for papers by Adina Figl Breakdown of academic impact, for papers by Philippe Pujuguet Breakdown of academic impact, for papers by Meghna Waghray Breakdown of academic impact, for papers by Dan Branstetter Breakdown of academic impact, for papers by Koroku Kato
Rankless by CCL
2026